SCHEMBL7564671

SCHEMBL7564671

O=[C]N1CCC(c2ccc(CCOC(c3ccccc3)(c3ccccc3)c3ccccc3)cc2)C(O)C1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 3/20 0.40
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
SLC18A3 Q16572 1/20 0.36
SLC6A11 P48066 1/20 0.35
HTT P42858 1/20 0.35
CYP2C9 P11712 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KIF11 P52732 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6041923 0.84 SLC6A1 (0.43) SLC6A1CHRM2CHRM4CHRM5CHRM1
SCHEMBL7077994 0.82 SLC6A1 (0.41) SLC6A1CHRM2CHRM4CHRM5CHRM1
SCHEMBL7084618 0.78 SLC6A1 (0.38) SLC6A1CHRM2CHRM4CHRM5CHRM1
SCHEMBL7593801 0.75 REN (0.41) KIF11
SCHEMBL6043281 0.73 SLC6A1 (0.39) SLC6A1SLC18A3SLC6A11HTTCYP2C19
SCHEMBL6958316 0.72 SLC6A1 (0.38) SLC6A1CHRM3SLC18A3SLC6A11HTT
SCHEMBL6042383 0.70 SLC6A1 (0.39) SLC6A1CHRM2CHRM1CHRM3SLC18A3
SCHEMBL6041453 0.68 REN (0.46)
SCHEMBL6951927 0.67 TACR1 (0.36) SLC6A1SLC18A3SLC6A11HTTMEN1
SCHEMBL9142722 0.66 KIF11 (0.52) CYP2C19KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076440-A2 METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES ELAN PHARMACEUTICALS, INC. (US) 2002-10-03 WO disclosed